Beskrivning
| Land | Finland |
|---|---|
| Lista | First North Finland |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Nightingale Health Plc - Managers' transactions - 25 March 2021 9:30 a.m. (Finnish time)
Nightingale Health Plc - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Soininen, Timo
Position: Member of the Board/Deputy member
Issuer: Nightingale Health Oyj
LEI: 743700WUIPC24LVMLO66
Notification type: INITIAL NOTIFICATION
Reference number: 743700WUIPC24LVMLO66_20210324144018_2
____________________________________________
Transaction date: 2021-03-24
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000490875
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 4 Unit price: 5.68 EUR
(2): Volume: 754 Unit price: 5.68 EUR
(3): Volume: 444 Unit price: 5.66 EUR
(4): Volume: 41 Unit price: 5.7 EUR
(5): Volume: 415 Unit price: 5.7 EUR
(6): Volume: 100 Unit price: 5.7 EUR
(7): Volume: 500 Unit price: 5.68 EUR
(8): Volume: 581 Unit price: 5.72 EUR
(9): Volume: 100 Unit price: 5.7 EUR
(10): Volume: 146 Unit price: 5.74 EUR
(11): Volume: 331 Unit price: 5.74 EUR
(12): Volume: 174 Unit price: 5.74 EUR
(13): Volume: 430 Unit price: 5.6 EUR
(14): Volume: 368 Unit price: 5.6 EUR
(15): Volume: 151 Unit price: 5.58 EUR
(16): Volume: 255 Unit price: 5.6 EUR
(17): Volume: 200 Unit price: 5.58 EUR
(18): Volume: 458 Unit price: 5.5 EUR
(19): Volume: 458 Unit price: 5.5 EUR
(20): Volume: 447 Unit price: 5.5 EUR
(21): Volume: 530 Unit price: 5.5 EUR
(22): Volume: 411 Unit price: 5.46 EUR
(23): Volume: 10 Unit price: 5.44 EUR
(24): Volume: 50 Unit price: 5.44 EUR
(25): Volume: 310 Unit price: 5.46 EUR
(26): Volume: 169 Unit price: 5.5 EUR
(27): Volume: 292 Unit price: 5.5 EUR
(28): Volume: 505 Unit price: 5.54 EUR
(29): Volume: 266 Unit price: 5.5 EUR
(30): Volume: 100 Unit price: 5.5 EUR
Aggregated transactions
(30): Volume: 9,000 Volume weighted average price: 5.59265 EUR
For further information, please contact:
Teemu Suna, CEO
ir@nightingalehealth.com,tel. +358 20 730 1810
Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670
About Nightingale
Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. By combining our pioneering blood-testing technology and the ability to detect future disease risks, we are creating a world-leading health data platform that enables preventative care with better information. The platform helps people make better personal health decisions and connects the health industry to offer their services for individuals' preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone.